Radiotherapy capacity required in Scotland in 2015 Sara C Erridge Carrie Featherstone.

Slides:



Advertisements
Similar presentations
Comparison of survival following colorectal cancer in England, Northern Ireland, Scotland and the Nordic countries using period survival methods Gerda.
Advertisements

Modelling Radiotherapy Tim Cooper National Cancer Action Team.
Cancer of Unknown Primary
Exploring uncertainty in cost effectiveness analysis NICE International and HITAP copyright © 2013 Francis Ruiz NICE International (acknowledgements to:
Adjustments for Age-sex and MLC NRAC 29 March 2007.
Evaluation of Femur Fracture Risk in Soft-Tissue Sarcoma of the Thigh Treated with Intensity- Modulated Radiation Therapy (IMRT) Michael R. Folkert, MD.
Case-Control Studies (Retrospective Studies). What is a cohort?
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
In Search of Efficiency, Consistency, Fairness, and Impact in HTA: Modelling screening and treatment pathways for diabetic retinopathy Graham Scotland.
Nicola Barnstaple Programme Manager. Key challenges in Scotland Increasing cancer incidence – predicted 35,000 cases per year in 2020 Ageing population.
Summary Measures of Population Health: Measuring the impact of disease, injuries and risk factors.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
What is the role of free PSA? Total PSA Range 2.5 to 4.0 ng/ml Age Range (Years) %Free PSA=60 (yrs)All Ages
Journal Club Alcohol, Other Drugs, and Health: Current Evidence April 2008.
Meta-Analysis of PSA Growth Lurdes Y.T. Inoue, Ph.D. Ruth Etzioni, Ph.D. Elizabeth Slate, Ph.D. Christopher Morrel, Ph.D.
SOME ADDITIONAL POINTS ON MEASUREMENT ERROR IN EPIDEMIOLOGY Sholom May 28, 2011 Supplement to Prof. Carroll’s talk II.
Is the rate of biological ageing, as measured by age at diagnosis of cancer, socio-economically patterned? Dr. Jean Adams School of Population and Health.
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
SPARRA Peter Martin Programme Principal Long Term Conditions/Joint Future Programmes.
Waiting times for radiotherapy: variation over time and between cancer networks in southeast England David Robinson, Tom Massey & Henrik Møller Thames.
Diane Stockton Trend analysis. Introduction Why do we want to look at trends over time? –To see how things have changed What is the information used for?
Study Design / Data: Case-Control, Descriptives Basic Medical Statistics Course: Module C October 2010 Wilma Heemsbergen
Indianapolis Discovery Network for Dementia Forecasting the Future Impact of Early Detection and Management Program for Alzheimer.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Extending the Gail model for Breast Cancer Risk Prediction to Account for Modifiable Factors in the Italian Population. Calza S, Ferraroni M, Decarli A.
Biomechanics and biology: bridging the gap Sam Evans School of Engineering
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 4: Taking Risks and Playing the Odds: OR vs.
GM Monawar Hosain State Cancer Epidemiologist Bureau of Public Health Statistics and Informatics NH Division of Pubic Health Services.
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
A role for lipids and statins in breast cancer risk and prevention? Dr. Mieke Van Hemelrijck Senior Lecturer in Cancer Epidemiology 3 August 2015.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
How do we know whether a marker or model is any good? A discussion of some simple decision analytic methods Carrie Bennette (on behalf of Andrew Vickers)
“The African American Prostate Cancer Crisis in Numbers”
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
Methodology for producing the revised back series of population estimates for Julie Jefferies Population and Demography Division Office for.
Software Project Management By Deepika Chaudhary.
Validity of more than 30Gy radiation therapy for long-surviving patients with painful bone metastases E.Katayama 1,2, H.Okada 1, I.Asakawa 2, T.Tamamoto.
Better information --> better decisions --> better health1 Projections of cancer incidence in Scotland to 2020 Roger Black, Samuel Oduro, David Brewster.
A short introduction to epidemiology Chapter 2b: Conducting a case- control study Neil Pearce Centre for Public Health Research Massey University Wellington,
Rates, Ratios and Proportions and Measures of Disease Frequency
A Moment of Time: Reliability in Route Choice using Stated Preference David M. Levinson Nebiyou Y. Tilahun Department of Civil Engineering University of.
Leicester Warwick Medical School Health and Disease in Populations Case-Control Studies Paul Burton.
Urban-Rural Inequalities in Potentially Preventable Hospital Admissions Carolyn Hunter-Rowe Senior Health Intelligence Analyst Department of Public Health.
What is shared decision making? Richard Thomson Professor of Epidemiology and Public Health Associate Dean for Patient and Public Engagement Decision Making.
Comparing 2 Proportions © 2006 W.H. Freeman and Company.
A.N.N.C.R.I.P.S The Artificial Neural Networks for Cancer Research in Prediction & Survival A CSI – VESIT PRESENTATION Presented By Karan Kamdar Amit.
Prognosis study EBM questions. Prognostic factors Characteristics of patient that may predict eventual outcome Several types: demographic (eg age) disease-specific.
K = K = K = 100.
Assessing Estimability of Latent Class Models Using a Bayesian Estimation Approach Elizabeth S. Garrett Scott L. Zeger Johns Hopkins University Departments.
Measures of Disease Frequency
Topics and Questions. All quantitative research begins with a question of some kind. The title may suggest the type of question being posed. The research.
BC Cancer Agency CARE & RESEARCH Breast Cancer Mortality After Screening Mammography in British Columbia Women Andrew J. Coldman, Ph.D. Norm Phillips,
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
III. Measures of Morbidity: Morbid means disease. Morbidity is an important part of community health. It gives an idea about disease status in that community.
IS THERE A RATIONAL APPROACH TO RADIATION RISK? Philip F. Judy Ph.D. Department of Radiology Brigham and Women's Hospital New England AAPM Chapter Meeting.
Using SEER-Medicare Data to Enhance Registry Data to Assess Quality of Care Joan Warren Applied Research Program National Cancer Institute NAACCR June.
Appendix 2 Comparison of screening from age 20 and age 25 Table of harms and benefits.
South West Public Health Observatory The changing casemix of prostate cancer patients and prostatectomies in the South West Sean McPhail.
Developed from information included in the AIHW report Cancer in Australia: in brief 2014 Highlights.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
Completeness of linking identifiers Combining database structures South West Public Health Observatory Development of a urological cancer.
Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
Colin Fischbacher Information Services Division (ISD)
Nat. Rev. Clin. Oncol. doi: /nrclinonc
The Research Question 1) What is the contemporary prevalence of Active Surveillance (AS) adoption among men newly diagnosed with low-risk localized prostate.
Prevalence of germline T790M.
Presentation transcript:

Radiotherapy capacity required in Scotland in 2015 Sara C Erridge Carrie Featherstone

Scottish RT models RT capacity required depends on  Number of new cancer patients  Types of cancer  Proportion needing RT  Fractionation schedule used  Complexity of treatments e.g. IGRT  Spare capacity to avoid waiting times /R&D etc

Scottish Models In 2005 Scottish Activity Report suggested that by 2015 potential 38% to 81% increase in machine capacity required 270,000 and 354,000 fractions Given as total number of fractions as can be delivered on variable number of machines depending on hours worked, through-put etc

Scottish Models –weaknesses Some sites no Scottish data could be identified (e.g. prostate) – we had to use NYCRIS or the Australian data Predictions of future can be affected by other factors e.g. informal PSA screening Models are just models……… some will always work better than others

Calculating demand Proportion of patients who fit into different cancer scenarios Population-based (>90% cases) Factors  Cancer type  Stage  Performance status  Co-morbidity  Patient/physician preference Difficulty

Revised models Step 1 – predicting the number of cancer patients

Data and methods Historical incidence data GRO population estimates GRO population projections Age-Period-Cohort models using software developed by the Norwegian Cancer Registry (NORDPRED) Conducted by Sam Oduro, David Brewster, Roger

Lung cancer risk varies by birth cohort Source: Swerdlow et al, 1998

Age-Period-Cohort models Model works by estimating the simultaneous influence of age, period and birth cohort on individual risk Cohort effects highly predictable Future period effects not so, e.g. new screening programme, diagnostic test

Source: GRO(S) We have consistently underestimated population growth in Scotland …

Source: GRO(S) … and most of the growth is in people aged 75+

Results (average number of new cases per annum)

Validation

Comment on results Results reasonably reliable for most of the common cancers and the total Concern about prostate cancer (period effect) We usually adopted the most conservative results from the range of model predictions Model choice is always to some extent subjective

Conclusion New cancer cases expected to increase by approximately 18% every 10 years This is mainly due to our aging population Results for Scotland compatible with those for England (33% increase from 2001 to 2020).